Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 371 - 380 of 417

Selected Filters:
6 January 2020

What Have We Learned About Adolescent Girls and Young Women and HIV Prevention?

Using survey data collected from ongoing, planned and completed projects studying HIV prevention for adolescent girls and young women, it is possible to identify trends and gaps in the data, and provide a clear snapshot of what we know now.

Research

Document
10 October 2019

The Dapivirine Ring: Key learnings from like-product introductions

Vaginal insertion and partial efficacy are two challenges that could affect the uptake and continued use of the dapivirine ring. Analyses of the introductions of other products that share similar characteristics provide useful lessons to inform planning for rollout of the dapivirine ring. This paper provides information for planners, implementers, funders, researchers, trainers, providers of…

Research

Document
10 October 2019

Social Harms and Use of the Dapivirine Vaginal Ring

The dapivirine ring and other woman-initiated HIV prevention methods are designed to enable women to have more control over their sexual health and risk of HIV exposure, but research has revealed that women's male partners often influence their ability to use these methods. This brief summarizes an analysis of MTN-020/ASPIRE trial data, which showed that…

Research

Document
6 August 2019

MTN-003D

Archived from the MTN website before it was taken down. Primary Objectives Explore larger contextual issues and specific aspects of the VOICE trial that positively and negatively affected participants’ actual and reported product use. Explore the reasons, motivations, and context of engaging in receptive anal intercourse, (and rectal use of gel among VOICE participants in…

Research

14 June 2019

OPTIONS Plan 4 PrEP Toolkit: Private Health Sector Landscape

Step 6 in a six-part toolkit to assist implementers rolling out oral PrEP. Assess and compare opportunities to delivery oral PrEP through private sector healthcare channels.

Community/Advocacy, Research, Service Delivery

Document
9 May 2019

Test-And-Prevent Analysis: Key findings

Significant resources have created strong test and treat™ programs globally. What about those who test HIV negative? How can we strengthen linkage of HIV-negative individuals to prevention programs in ways that work for them? In our recently completed Test-And-Prevent Analysis, the OPTIONS Consortium identifies practices for linking individuals from HIV testing to HIV prevention. This…

Research, Monitoring & Evaluation, Testing

Document
7 May 2019

HIV Prevention Market Manager Summary Document

An 18 slide overview of the goals, approaches and challenges faced by the HIV Prevention Market Manager project. A two-page overview is also available.

Research

Document
17 April 2019

Health care providers’ knowledge, attitudes, and practices (KAP) relevant to oral PrEP service provision to AGYW in Zimbabwe Preliminary Qualitative Findings

This study of knowledge, attitudes and practices (KAP) among health care providers in Zimbabwe explores questions about PrEP services for adolescent girls and young women. The findings offer insights that can be applied to provider training and support.

Research, Service Delivery

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Tanzania Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Tanzania was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Malawi Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Malawi was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document